Jan Fiedler

Title: Jan Fiedler: Innovator in Angiogenesis Research

Introduction

Jan Fiedler is a prominent inventor based in Hannover, Germany. He has made significant contributions to the field of pharmaceutical compositions, particularly in the area of long non-coding RNAs (lncRNAs) for therapy and diagnosis of angiogenesis. With a total of 3 patents, Fiedler's work is paving the way for innovative treatments in this critical area of medical research.

Latest Patents

Fiedler's latest patents focus on the development of pharmaceutical compositions that involve compounds promoting or inhibiting the expression and activity of specific lncRNAs. His inventions include compositions that target lncRNAs selected from various sequences, aiming to enhance therapeutic outcomes in angiogenesis-related conditions. These patents represent a significant advancement in understanding and manipulating lncRNAs for medical applications.

Career Highlights

Throughout his career, Jan Fiedler has worked with esteemed institutions such as Medizinische Hochschule Hannover and Julius-Maximilians-Universität Würzburg. His research has been instrumental in advancing the understanding of lncRNAs and their potential therapeutic applications. Fiedler's dedication to innovation in the medical field has established him as a key figure in angiogenesis research.

Collaborations

Fiedler has collaborated with notable professionals in his field, including Thomas Thum. These partnerships have further enriched his research and contributed to the development of groundbreaking therapeutic strategies.

Conclusion

Jan Fiedler's contributions to the field of angiogenesis research through his innovative patents and collaborations highlight his role as a leading inventor. His work continues to inspire advancements in medical therapies, showcasing the importance of research in improving health outcomes.